Fundraising FoxPhost'in Therapeutics
1 known investors
Find your way into Phost'in Therapeutics
Sign up to see every warm intro you have to Phost'in Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phost'in Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Phost'in Therapeutics is a Montpellier, France-based clinical-stage biopharmaceutical company developing small-molecule N-glycosylation modifiers, including GnT-V inhibitor PhOx430, to counter immune evasion in solid tumors and fibrotic diseases.
Investors · 1
Frequently asked questions
- What does Phost'in Therapeutics do?
- Phost'in Therapeutics is a Montpellier, France-based clinical-stage biopharmaceutical company developing small-molecule N-glycosylation modifiers, including GnT-V inhibitor PhOx430, to counter immune evasion in solid tumors and fibrotic diseases.
- Who are Phost'in Therapeutics's investors?
- Phost'in Therapeutics's investors include Remiges Ventures, Inc..